TABLE 2.
Prophylactic regimens for PCPa
| Drug name | Dose | Notes | Adverse drug events and side effects |
|---|---|---|---|
| Trimethoprim sulfamethoxazole | One single- or double-strength tab po daily or one double-strength tab po three times a week | Drug-drug interactions with ACEi/ARB/spironolactone Doubles as prophylaxis against other pathogens (e.g., toxoplasma) and several bacterial infections (respiratory, enteric, and urinary pathogens); if used for this dual purpose, 1 DS tab daily may be considered. When selecting the regimen, balance toxicity vs efficacy. |
Rash (including Stevens-Johnson syndrome), hyperkalemia, increased creatinine, transaminase elevation, neutropenia, and thrombocytopenia |
| Atovaquone | 1,500 mg po daily | Should be taken with a fatty meal to increase absorption Can be expensive and has an unpleasant taste |
Gastrointestinal upset, diarrhea, fever, transaminase elevation, and rash |
| Dapsone | 100 mg po daily (if toxoplasma serology is negative) Up to 200 mg daily combined with pyrimethamine and folinic acid (if toxoplasma serology is positive) |
Option to combine with pyrimethamine for cross-protection against toxoplasmosis Screen for G6PD deficiency prior to use. |
Rash, fever, nausea/vomiting, hemolytic anemia, methemoglobinemia, and transaminase elevation |
| Aerosolized pentamidine | 300 mg monthly via nebulizer Biweekly dosing has also been studied |
Requires specialized personnel and equipment Potential to transmit respiratory pathogens Risk of isolated apical disease or extrapulmonary disease |
Bronchospasm and cough |
1823 G6PD, glucose-6-phosphate dehydrogenase; ACEi, acetylcholinesterase inhibitor; ARB, angiotensin receptor blocker; DS, double strength; po, per os.